Moderna, Inc. - Special Call Transcript
Good morning, and welcome to the Moderna's conference call where we will discuss the impact of the COVID-19 on business operations and clinical program development. You can access the press release issued last night by going to the Investors section of our website.
Today on this call, we have Stéphane Bancel, Chief Executive Officer; Stephen Hoge, President; Tal Zaks, Chief Medical Officer; Lorence Kim, Chief Financial Officer; Juan Andres, Chief Technical Operations and Quality Officer; and Tracey Franklin, Chief Human Resources Officer.
Before we begin, I would like to remind everyone that this conference call will include forward-looking statements. Please see the bottom of the issued press release and our SEC filings for important risk factors that could cause our actual performance and results to differ materially from those expressed or implied in these forward-looking statements. We undertake no obligation to update or revise the information provided on this call as a result of new information or future results or developments.
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |